Resource Library

Whitepapers

Optimizing drug development through Samsung Biologics' customized CMC Solutions

Whitepapers - Optimizing drug development through Samsung Biologics' customized CMC Solutions


During the drug development process, chemistry, manufacturing, and control (CMC) services are fundamental to ensure quality, safety, and efficacy standards. Therefore, clients search for CDMO companies that can provide this model to help improve and streamline their operations. 


This whitepaper introduces Samsung Biologics’ customized CMC development services comprising three distinct packages:

 

  • Simplified IND package
  • Comprehensive IND package 
  • Enhanced CMC package


Packaged CMC services for streamlined drug development


Chemistry, manufacturing, and controls (CMC) services are a fundamental element of the drug development process, ensuring a product is consistently manufactured to meet quality, safety, and efficacy standards. In addition to satisfying regulatory requirements for data surrounding the product and its manufacture, CMC’s inherent process optimization contributes to accelerated timelines, lower overall project costs, and minimized risks. 

 

Tailored CMC development services also can lead to shorter global licensing timelines and minimize variability in globally registered product details. Still, drug and biologics developers too often settle for the one-size-fits-all service based on a standard CDMO business model, rather than customizable approaches to serve specific client needs. Utilizing workshops to collect and apply client input toward improving and streamlining our operations, Samsung Biologics developed its Customized CMC Solutions to help clients overcome this common hurdle. 

 

Through these modularized service packages, we ensure maximum flexibility for our partners during early-phase drug development by customizing our CMC services according to clients’ shifting demands. We have implemented three base concepts to provide product-specific solutions for a range of clients—from those targeting accelerated timelines that need only the essential components to file an Investigational New Drug (IND) application to those seeking a detailed study and/or enhancement of their molecules.

Whitepapers - Optimizing drug development through Samsung Biologics' customized CMC Solutions


During the drug development process, chemistry, manufacturing, and control (CMC) services are fundamental to ensure quality, safety, and efficacy standards. Therefore, clients search for CDMO companies that can provide this model to help improve and streamline their operations. 

 

This whitepaper introduces Samsung Biologics’ customized CMC development services comprising three distinct packages:

 

  • Simplified IND package
  • Comprehensive IND package 
  • Enhanced CMC package


Packaged CMC services for streamlined drug development


Chemistry, manufacturing, and controls (CMC) services are a fundamental element of the drug development process, ensuring a product is consistently manufactured to meet quality, safety, and efficacy standards. In addition to satisfying regulatory requirements for data surrounding the product and its manufacture, CMC’s inherent process optimization contributes to accelerated timelines, lower overall project costs, and minimized risks. 

 

Tailored CMC development services also can lead to shorter global licensing timelines and minimize variability in globally registered product details. Still, drug and biologics developers too often settle for the one-size-fits-all service based on a standard CDMO business model, rather than customizable approaches to serve specific client needs. Utilizing workshops to collect and apply client input toward improving and streamlining our operations, Samsung Biologics developed its Customized CMC Solutions to help clients overcome this common hurdle. 

 

Through these modularized service packages, we ensure maximum flexibility for our partners during early-phase drug development by customizing our CMC services according to clients’ shifting demands. We have implemented three base concepts to provide product-specific solutions for a range of clients—from those targeting accelerated timelines that need only the essential components to file an Investigational New Drug (IND) application to those seeking a detailed study and/or enhancement of their molecules.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION